New biotech Semma Therapeutics stem cell diabetes arena - The Niche
A new startup, Semma Therapeutics, announced it seeks to fight diabetes via translating technology from the lab of Doug Melton at Harvard to the clinic.
Professor Paul Knoepfler, Ph.D.
